Cleavage of cystatin C is not associated with multiple sclerosis

Annals of Neurology

Volumn 62, Issue 2, 2007, Pages 201-204

  Del Boccio, Piero ^a,b,c   Pieragostino, Damiana ^a,b,c   Lugaresi, Alessandra ^a,b   Di Ioia, Maria ^a,b   Pavone, Barbara ^a,b,c   Travaglini, Daniela ^a,b   D'Aguanno, Simona ^d,e   Bernardini, Sergio ^d,e   Sacchetta, Paolo ^a,b   Federici, Giorgio ^c,d,e   Di Ilio, Carmine ^a,b   Gambi, Domenico ^a,b   Urbani, Andrea ^a,b,c  

^a Centro Studi sull'Invecchiamento (CeSI)   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d Dipartimento di Medicina di Laboratorio

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C;

AMINO TERMINAL SEQUENCE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DIAGNOSTIC ERROR; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEOMICS; STORAGE;

ARTIFACTS; CYSTATINS; DRUG STORAGE; FREEZING; HUMANS; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS; PEPTIDE FRAGMENTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 35148898851     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20968     Document Type: Article

References (17)

1. Mc Farlin DE, Mc Farlan HF. Multiple sclerosis. N Engl J Med 1982;307:1183-1188.
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-952.
3. White RF. Emotional and cognitive correlates of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1990;4:422-428.
4. Brassington JC, Marsh NV. Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 1998;2:43-77.
5. Del Boccio P, Urbani A. Homo sapiens proteomics: clinical perspectives. Ann Ist Super Sanita 2005;41:479-482.
6. Veenstra TD, Conrads TP, Hood BL, et al. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 2005;4:409-418.
7. Maddalo G, Petrucci F, Iezzi M, et al. Analytical assessment of MALDI-TOF imaging mass spectrometry on thin histological samples. An insight in proteome investigation. Clin Chim Acta 2005;357:210-218.
8. Dekker LJ, Boogerd W, Stockhammer G, et al. MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer. Mol Cell Proteomics 2005;4:1341-1349.
9. Carete O, Demalte I, Scherl A, et al. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 2003;3:1486-1494.
10. Sanchez JC, Guillaume E, Lescuyer P, et al. Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics 2004;4:2229-2233.
11. Biroccio A, Del Boccio P, Panella M, et al. Differential posttranslational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics 2006;6:2305-2313.
12. Villanueva J, Philip J, Chaparro CA, et al. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 2005;4:1060-1072.
13. Carlson SM, Najmi A, Whitin JC, Cohen HJ. Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra. Proteomics 2005;5:2778-2788.
14. Irani DN, Anderson C, Gundry R, et al. Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 2006;59:237-247.
15. Carrette O, Burkhard PR, Hughes S, et al. Truncated cystatin C in cerebrospinal fluid: technical [corrected] artefact or biological process? Proteomics 2005;5:3060-3065.
16. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
17. Frohman EM, Goodin DS, Calabresi PA, et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;61:602-611.